vs
HARTE HANKS INC（HHS）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是HARTE HANKS INC的1.8倍（$69.8M vs $39.9M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 5.5%，领先378.5%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -15.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -6.4%）
哈特·汉克斯是一家总部位于美国马萨诸塞州波士顿的全球营销服务企业，主营业务涵盖数据分析、营销战略规划、营销技术支持、创意服务、数字营销、客户服务、直邮服务以及物流履约等多个领域，为全球客户提供全方位的营销解决方案。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
HHS vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.8倍
$39.9M
营收增速更快
RIGL
高出36.6%
-15.4%
净利率更高
RIGL
高出378.5%
5.5%
两年增速更快
RIGL
近两年复合增速
-6.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $39.9M | $69.8M |
| 净利润 | $2.2M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -0.3% | 33.2% |
| 净利率 | 5.5% | 384.0% |
| 营收同比 | -15.4% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.30 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HHSRIGL
| Q4 25 | $39.9M | $69.8M | ||
| Q3 25 | $39.5M | $69.5M | ||
| Q2 25 | $38.6M | $101.7M | ||
| Q1 25 | $41.6M | $53.3M | ||
| Q4 24 | $47.1M | $57.6M | ||
| Q3 24 | $47.6M | $55.3M | ||
| Q2 24 | $45.0M | $36.8M | ||
| Q1 24 | $45.4M | $29.5M |
净利润HHSRIGL
| Q4 25 | $2.2M | $268.1M | ||
| Q3 25 | $-2.3M | $27.9M | ||
| Q2 25 | $-335.0K | $59.6M | ||
| Q1 25 | $-392.0K | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $142.0K | $12.4M | ||
| Q2 24 | $-27.8M | $-1.0M | ||
| Q1 24 | $-171.0K | $-8.2M |
毛利率HHSRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率HHSRIGL
| Q4 25 | -0.3% | 33.2% | ||
| Q3 25 | 1.3% | 40.9% | ||
| Q2 25 | 0.1% | 60.1% | ||
| Q1 25 | -0.1% | 23.9% | ||
| Q4 24 | -3.3% | 28.9% | ||
| Q3 24 | 4.0% | 25.4% | ||
| Q2 24 | 3.0% | 1.2% | ||
| Q1 24 | 0.8% | -23.6% |
净利率HHSRIGL
| Q4 25 | 5.5% | 384.0% | ||
| Q3 25 | -5.8% | 40.2% | ||
| Q2 25 | -0.9% | 58.6% | ||
| Q1 25 | -0.9% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 0.3% | 22.5% | ||
| Q2 24 | -61.8% | -2.8% | ||
| Q1 24 | -0.4% | -27.9% |
每股收益（稀释后）HHSRIGL
| Q4 25 | $0.30 | $14.11 | ||
| Q3 25 | $-0.31 | $1.46 | ||
| Q2 25 | $-0.05 | $3.28 | ||
| Q1 25 | $-0.05 | $0.63 | ||
| Q4 24 | $-0.31 | $0.82 | ||
| Q3 24 | $0.02 | $0.70 | ||
| Q2 24 | $-3.84 | $-0.06 | ||
| Q1 24 | $-0.02 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.6M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $20.5M | $391.5M |
| 总资产 | $91.8M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资HHSRIGL
| Q4 25 | $5.6M | $155.0M | ||
| Q3 25 | $6.5M | $137.1M | ||
| Q2 25 | $4.8M | $108.4M | ||
| Q1 25 | $9.0M | $77.1M | ||
| Q4 24 | $9.8M | $77.3M | ||
| Q3 24 | $5.9M | $61.1M | ||
| Q2 24 | $11.0M | $49.1M | ||
| Q1 24 | $11.5M | $49.5M |
总债务HHSRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益HHSRIGL
| Q4 25 | $20.5M | $391.5M | ||
| Q3 25 | $19.9M | $117.6M | ||
| Q2 25 | $22.2M | $81.9M | ||
| Q1 25 | $21.4M | $18.6M | ||
| Q4 24 | $21.7M | $3.3M | ||
| Q3 24 | $21.0M | $-14.6M | ||
| Q2 24 | $20.6M | $-29.9M | ||
| Q1 24 | $20.0M | $-31.7M |
总资产HHSRIGL
| Q4 25 | $91.8M | $513.6M | ||
| Q3 25 | $92.7M | $242.5M | ||
| Q2 25 | $95.0M | $206.7M | ||
| Q1 25 | $100.6M | $176.0M | ||
| Q4 24 | $101.8M | $164.0M | ||
| Q3 24 | $108.1M | $139.4M | ||
| Q2 24 | $109.7M | $128.4M | ||
| Q1 24 | $113.4M | $126.5M |
负债/权益比HHSRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $737.0K | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-686.0K | — |
| 自由现金流率自由现金流/营收 | -1.7% | — |
| 资本支出强度资本支出/营收 | 3.6% | — |
| 现金转化率经营现金流/净利润 | 0.33× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-4.5M | — |
8季度趋势，按日历期对齐
经营现金流HHSRIGL
| Q4 25 | $737.0K | $22.0M | ||
| Q3 25 | $3.2M | $24.0M | ||
| Q2 25 | $-4.8M | $30.5M | ||
| Q1 25 | $-818.0K | $-893.0K | ||
| Q4 24 | $4.0M | $14.5M | ||
| Q3 24 | $-2.9M | $21.7M | ||
| Q2 24 | $1.6M | $302.0K | ||
| Q1 24 | $-5.7M | $-5.0M |
自由现金流HHSRIGL
| Q4 25 | $-686.0K | — | ||
| Q3 25 | $2.2M | — | ||
| Q2 25 | $-5.1M | — | ||
| Q1 25 | $-923.0K | — | ||
| Q4 24 | $3.4M | — | ||
| Q3 24 | $-4.9M | — | ||
| Q2 24 | $926.0K | — | ||
| Q1 24 | $-6.2M | — |
自由现金流率HHSRIGL
| Q4 25 | -1.7% | — | ||
| Q3 25 | 5.5% | — | ||
| Q2 25 | -13.1% | — | ||
| Q1 25 | -2.2% | — | ||
| Q4 24 | 7.3% | — | ||
| Q3 24 | -10.2% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | -13.7% | — |
资本支出强度HHSRIGL
| Q4 25 | 3.6% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 1.3% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 1.2% | — |
现金转化率HHSRIGL
| Q4 25 | 0.33× | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | -20.76× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HHS
| Fulfillment And Logistics Services | $17.3M | 43% |
| Customer Care | $13.7M | 34% |
| Other | $8.9M | 22% |
RIGL
暂无分部数据
